Facebook WhatsApp Previous articleGlobal $79.23 Bn Regenerative Medicine Markets, Analysis 2015-2019 & Forecasts 2020-2026 – ResearchAndMarkets.comNext articleTellurian Reports 2020 Results Digital AIM Web Support Pinterest By Digital AIM Web Support – February 24, 2021 Pinterest Global Virtual Clinical Trials Market Report 2020-2027: Players are Strategizing on Developing New Virtual Clinical Trial Technology to Cope with the Augmenting Healthcare Industry – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–Feb 24, 2021– The “Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design; By Indication; By Phases; By Regions; Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering. The global virtual clinical trials market size is expected to reach USD 13.78 billion by 2027 Virtual Clinical Trials (VCT) are a new method of directing clinical trials which is inclusive of web platforms (informed consent, recruitment, adverse reactions, counseling and measurement of endpoints) and taking advantage of technology such as monitoring devices, apps and others. VCT also allows participant to be home-based at all clinical trial stage. VCT are operationally feasible and have lower drop-out rates, higher recruitment rates, better compliance and are faster than traditional method. The growth of virtual clinical trials is mainly owing to the advantages offered by these trials in place of traditional clinical trials. The cost of development of a new drug estimates more than a 2 billion dollars and approximately two-third of the total cost is consumed in clinical testing phase. Moreover, delay in clinical trials is majorly caused by patient recruitment resulting in loss of revenue of millions of dollars per day for the pharmaceutical companies. Furthermore, participant drop out is another major challenges faced in the clinical testing. To overcome these challenges major healthcare and pharmaceutical companies and organizations are constantly aiming on adopting new technology by investing in virtual clinical trial solutions, which is expected to escalate the overall market on a global level. The prominent factors favoring the global market growth include scarcity of time in traditional clinical trials, rising R&D for the development of new drugs and vaccines, adoption of telemedicine and increasing demand for patient diversity. Additionally, COVID-19 pandemic has led to upsurge virtual clinical trials given the trials need to be conducted digitally. Thereby, companies all around the globe are aiming on developing virtual trial technologies to meet the growing demand for solutions to fight Covid-19. For instance, in June 2020, TRHC (Tabula Rasa HealthCare), developer of healthcare software solutions, announced its partnership with Regence BlueShield, a health plan provider, for conducting virtual trials for different drug candidates, and to examine the ADEs (adverse drug events) in each. Market participants such as LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Oracle Corporation, Medable, Inc., Parexel International, Clinical Ink, Inc., PRA Health Sciences, Science 37 and ICON plc. are some of the key players operating in the global market. Players in the market are strategizing on developing new virtual clinical trial technology to cope up with the augmenting healthcare industry and thereby, establish their market place. For instance, in May 2020, AiCure LLC, an advanced data analytics and artificial intelligence company, partnered with Science 37, a clinical research company, to leverage a decentralized research model for enabling home based clinical trial for assessing an experimental drug for major depression disorder (MDD). Key Topics Covered: 1. Introduction 2. Executive Summary 3. Research Methodology 4. Virtual Clinical Trials Market Insights 4.1. Virtual Clinical Trials – Industry snapshot 4.2. Virtual Clinical Trials Market Dynamics 4.2.1. Drivers and Opportunities 188.8.131.52. Need for digitization in clinical trials 184.108.40.206. Fear among clinical investigators for COVID-19 4.2.2. Restraints and Challenges 220.127.116.11. High upfront costs 4.3. Porter’s Five Forces Analysis 4.4. PESTLE Analysis 4.5. Virtual Clinical Trials Market Industry trends 5. Virtual Clinical Trials Market Assessment by Design 5.1. Key Findings 5.2. Introduction 5.3. Observational Trials 5.4. Interventional Trials 5.5. Expanded Access Trials 6. Global Virtual Clinical Trials Market, by Indication 6.1. Key Findings 6.2. Introduction 6.3. CNS 6.4. Autoimmune/Inflammation 6.5. Cardiovascular Disease 6.6. Metabolic/Endocrinology 6.7. Infectious Disease 6.8. Oncology 6.9. Genitourinary 6.10. Ophthalmology 7. Global Virtual Clinical Trials Market, by Phases 7.1. Key Findings 7.2. Introduction 7.3. Phase I 7.4. Phase II 7.5. Phase III 7.6. Phase IV 8. Virtual Clinical Trials Market Assessment by Geography 8.1. Key findings 8.2. Introduction 8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2016- 2027 (USD Million) 9. Competitive Landscape 9.1. Expansion and Acquisition Analysis 9.1.1. Expansion Analysis 9.1.2. Acquisition Analysis 9.2. Partnerships/Collaborations/Agreements/Exhibitions 10. Company Profiles 10.1. Company Overview 10.2. Financial Performance 10.3. Product Benchmarking 10.4. Recent DevelopmentsLEO Innovation LabCovance Inc.CRF HealthOracle CorporationMedable Inc.Paraxel InternationalClinical Ink Inc.PRA Health SciencesScience 37ICON plc For more information about this report visit https://www.researchandmarkets.com/r/ykymg1 View source version on businesswire.com:https://www.businesswire.com/news/home/20210224005573/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/24/2021 07:37 AM/DISC: 02/24/2021 07:37 AM http://www.businesswire.com/news/home/20210224005573/en TAGS Twitter Local NewsBusiness Twitter WhatsApp Facebook
WVEC-TV(NEWPORT NEWS, Va.) — A white hotel clerk in Southern Virginia was fired this week after video surfaced showing that he called a black customer a “f–king monkey.”Country Inn & Suites by Radisson in Newport News, Virginia, said it fired the employee on Monday after Irby Fogleman shared video showing him arguing with the worker over room accommodations.In the video, the unidentified worker is heard yelling “get your family and get out” before muttering the racial epithet.Fogleman’s wife, Kelsey Cunningham, said the conformation started after her husband complained that one of their rooms smelled like smoke.“It’s hurtful. We have two small children that were also in the hotel,” Cunningham told ABC affiliate WVEC-TV. “It just shouldn’t be tolerated at this point, and that’s why we decided to share the video.”Cunningham, who’s white, said she and her family were there to visit her mother-in-law, who came to town to surprise them.“She went and picked her own hotel, which I kind of regret now,” Fogleman said. “We get into the room and smell smoke, and that was kind of alarming because she doesn’t smoke.”The Country Inn & Suites by Radisson said it would re-train its employees in the wake of the incident.“I want to apologize for the inappropriate behavior and comments of one of our employees from an incident that occurred on Friday, May 4,” the hotel’s general manager, Lisa Little, said in a statement. “As a result of this incident, we will also be re-training every employee this week on our code-of-conduct policies to help ensure something like this never happens again.”Cunningham said she and her family received “a scripted apology along with a refund” a few days after the encounter.“The last few days have been hurtful, stressful and really just exhausting,” she wrote in a Facebook post on Monday. “All I can do is hope this doesn’t happen to someone else.”Copyright © 2018, ABC Radio. All rights reserved.
Medlin later talked to SS and asked them to bring along their friends, LF and TR. Each child was promised Rp 2 million, Yusri went on to say.“[Medlin] asked one child to record his [sexual acts] with the other minors using his phone,” he said.Medlin, who entered Indonesia on a tourist visa last year, was apprehended at his residence on Monday after police questioned three minors.The US national has been on the Federal Bureau of Investigation’s (FBI) wanted list for crimes related to an investment scam in bitcoin stocks, Yunus said, adding the scam totaled $722 million. (rfa)Topics : The US authorities’ investigation found that Medlin recorded his sexual acts on video – a practice he would do again in his most recent crime involving an Indonesian child, according to Yusri.Read also: Children ‘trapped’ in pornography: KPAIDuring his stay in Jakarta, Medlin had contacted a local 20-year-old woman, identified only as A, who was known to have ties to child trafficking, the police spokesperson said.“[Medlin] asked A via WhatsApp to introduce him to a minor. A then introduced him to the victim, SS, who is still 15 years of age,” Yusri said. Russ Albert Medlin, an American fugitive recently arrested in Jakarta for alleged sexual assault against minors, is a known pedophile in his home country, according to Jakarta Police.Jakarta Police spokesperson Sr. Comr. Yusri Yunus said Medlin had previously been charged in connection to sexual violence against a 14-year-old in the United States prior to his arrest in Indonesia.“[He] was charged with sexual violence against a minor twice by a district court in Nevada between 2006 and 2008, and had served two years in prison,” he said on Tuesday, as quoted by kompas.com.